Keeping Current

Sep 23, 2025

Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers?
 
Credit available for this activity expires: 9/22/2026
Earn Credit / Learning Objectives & Disclosures:

Sep 19, 2025

Are you up to date on new treatment options for thyroid eye disease?

Credit available for this activity expires: 9/17/26
Earn Credit / Learning Objectives & Disclosures:

Sep 18, 2025

Discover how emerging B-cell-targeted therapies are transforming the treatment landscape and outcomes for patients with IgA nephropathy (IgAN).

Credit available for this activity expires: 9/18/26
Earn Credit / Learning Objectives & Disclosures:

Sep 11, 2025

Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer?

Credit available for this activity expires: 9/10/26
Earn Credit / Learning Objectives & Disclosures: